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tend to overestimate cognitive defi cits when compared 
to their caregiver’s assessment, AD patients in early 
stages of disease underestimate cognitive dysfunctions. 
Anosognosia can thus be regarded as a characteristic 
symptom at a stage of very mild AD (MMSE  6 24) but 
not MCI. Accordingly, medical history even in mildly af-
fected patients should always include information from 
both patient and caregiver. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 Anosognosia, the denial of illness, has frequently been 
described as a symptom of Alzheimer’s disease (AD)  [1–
4] . It has a major clinical relevance since it is directly re-
lated to the reliability of a patient’s complaints of dys-
function. Also, a relationship to everyday functioning  [5] 
and treatment outcome  [6] has been documented. 
 Anosognosia is a heterogeneous phenomenon which 
might be domain-speciﬁ c  [7, 8] and more pronounced for 
cognitive than for psychiatric and behavioral dysfunction 
in AD  [9] . Patients can be aware of their dysfunctions but 
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 Abstract 
 Objective: To study awareness of cognitive dysfunction 
in patients with very mild Alzheimer’s disease (AD) and 
subjects with mild cognitive impairment (MCI).  Meth-
ods: A complaint interview covering 13 cognitive do-
mains was administered to 82 AD and 79 MCI patients 
and their caregivers. The patient groups were compa-
rable according to age and education, and Mini Mental 
State Examination (MMSE) scores were  6 24 in all cases. 
The discrepancy between the patients’ and caregivers’ 
estimations of impairments was taken as a measure of 
anosognosia.  Results: Self-reports of cognitive diffi cul-
ties were comparable for AD and MCI patients. However, 
while in comparison to caregivers MCI patients reported 
signifi cantly more cognitive impairment (p  ! 0.05), AD 
patients complained signifi cantly less cognitive dysfunc-
tions (p  ! 0.001).  Conclusions: While most MCI patients 
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may negate their severity  [2] . Several sociodemographic, 
clinical and neuropsychological parameters have been 
proposed to be associated with self-unawareness in AD. 
Thus a possible inﬂ uence of age  [2] and gender  [5, 11] , 
but not education  [8, 10, 11], on anosognosia has been 
described (but see Vasterling et al.  [8] and Gil et al. [10] 
for different results concerning the factor age). Some stud-
ies found covariance of anosognosia with cognitive func-
tions such as memory  [2, 12] and executive functioning 
 [13–15] . Depression  [12, 16, 17] and anxiety  [2, 16] have 
been reported to be inversely related to anosognosia, 
while agitation and disinhibition are positively correlated 
to underestimation of dysfunction  [16] . Whether longer 
duration of illness is accompanied by increasing self-un-
awareness is still under debate  [5, 10, 18] . Another im-
portant issue is the possible relationship between anosog-
nosia and severity of dementia. Most  [2, 3, 5, 10, 15, 16, 
19–21] but not all  [13, 17, 18, 22] studies documented 
signiﬁ cant correlations between self-unawareness and 
overall cognitive functioning in AD, usually operational-
ized with the Mini Mental State Examination (MMSE 
 [23] ) or Clinical Dementia Rating Scale (CDR  [24] ). For 
clinical purposes, it appears important to concentrate on 
AD patients in their earliest stages (MMSE scores  6 24) 
or to examine how representative reports of dysfunctions 
are in patients with mild cognitive impairment (MCI) 
which is often regarded as a (pre-)clinical stage of demen-
tia  [25, 26] . A high percentage of these patients converts 
to dementia, most often to AD  [27, 28] . In a longitudinal 
design, Tabert et al.  [29] observed that unawareness of 
functional deﬁ cits (activities of daily living – ADL) exists 
in MCI patients and that it strongly predicts conversion 
to AD. However, MCI patients with impaired daily living 
activities might already be considered as very mild AD, 
and the question remains whether self-estimation of oth-
er domains such as cognitive functions is reliable in MCI 
patients. 
 The aim of our study was to assess awareness of cogni-
tive dysfunction in patients with very early stages of AD 
(MMSE scores  6 24) and in subjects with MCI. We fur-
ther investigated possible correlations of anosognosia 
with ADL and depressive symptoms – two factors which 
are both clinically relevant and have proven to be related 
to self-awareness in AD. For these purposes, a semistruc-
tured complaint interview on cognitive domains was ad-
ministered to patients and caregivers. Using a method 
which has been established in previous studies  [2, 13, 18] , 
the discrepancy between the two reports was taken as a 
measure of anosognosia. 
 Materials and Methods 
 Subjects 
 We included patients meeting criteria for dementia according 
to DSM-IV  [30] as well as NINCDS-ADRDA criteria  [31] for prob-
able AD. Severity of dementia was mild in all cases with MMSE 
scores of  6 24. In a second study group, subjects meeting Petersen 
criteria  [32] for MCI were enrolled in the study. Petersen criteria 
are (1)  subjective memory complaint as elicited by medical history, 
(2)  normal activities of daily living as reported by patients and care-
givers in medical history, (3)  normal general cognitive function de-
ﬁ ned as cognitive performance within the range of 1 standard de-
viation (SD) of normative data in an extensive neuropsychological 
test battery (see below), (4)  abnormal memory for age documented 
by performance of at least 1 SD below mean normative data in the 
delayed recall condition of the used verbal or nonverbal memory 
task (see below), (5)  not demented according to DSM-IV  [30] crite-
ria and excluded by fulﬁ lling criteria 2 and 3, and (6)  absence of 
psychiatric symptoms assessed during a clinical interview with the 
patient and a caregiver, and operationalized by the Neuropsychi-
atric Inventory  [33] . The groups were comparable for age, educa-
tion, and gender. All subjects were recruited in outpatient memory 
clinics or by referral from general practitioners in a multicenter 
study of the 5th EU Framework Program Network for Efﬁ ciency 
and Standardization of Dementia Diagnosis (NEST-DD) and gave 
their written consent according to the study protocol that had been 
approved by the institutional ethics committee. All patients under-
went an extensive neuropsychological, neurological, and physical 
examination (laboratory tests for thyroid function, vitamin B 12  lev-
el and folic acid level), and structural and functional brain imaging 
techniques (magnetic resonance imaging and  18 F-FDG positron 
emission tomography). Exclusion criteria for the study included 
head trauma with permanent brain lesion, hypothyroidism, epi-
lepsy, evidence of psychoactive substance abuse, and systemic dis-
ease that could account for disturbance of brain function. For each 
patient a caregiver or relative, usually spouse or adult child, living 
with the patient or seeing him weekly, was identiﬁ ed and adminis-
tered the psychological scales and complaint interview. 
 Cognitive Testing and Psychological Scales 
 The MMSE  [23] was used as a global measure of the cognitive 
status. The neuropsychological test battery included tests for differ-
ent aspects of memory (California Verbal Learning Test (CVLT) 
 [34] , delayed recall of the Rey-Osterrieth-Figure (ROF)  [35] , digit 
span forward and reverse  [36] ), speed of information processing and 
executive functioning (Trail-Making Test A and B  [37] ), visuocon-
structive abilities (copy of the ROF), word ﬂ uency and language 
comprehension (semantic ﬂ uency task ‘animals’  [35] , Token Test 
from the Aachen Aphasia Test  [38] ). To describe patients’ everyday 
functioning, the Lawton-Instrumental-Activities-of-Daily-Living 
(IADL) scale  [39] was administered to the patients’ caregivers. Note-
worthy, the eight items of the IADL scale did not always capture 
impairment in speciﬁ c hobbies occurring in very early AD. The 21-
item Hamilton Depression Rating Scale (HAMD  [40] ), also admin-
istered to caregivers, was taken to measure depressive symptoms. 
 Complaint Interview 
 All patients and caregivers were examined with a structured 
complaint interview covering 13 cognitive domains (memory, at-
tention, orientation to time, spatial orientation, ﬂ uency of speech, 
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word ﬁ nding, reading, writing, executive functioning, abstract 
thinking, praxia, number processing, and calculation). For evalua-
tion of each function, a ﬁ ve-stage rating scale was used from 1 = ‘no 
complaints’ to 2 = ‘mild’, 3 = ‘moderate’, 4 = ‘severe’ and 5 = ‘very 
severe impairment’. Functions were exempliﬁ ed with short ques-
tions (e.g. for memory: ‘Does it sometimes happen that you forget 
something when you go to the grocery, that you do not remember 
where you put the keys or that you do not remember dates that you 
have?’). The complaint scores of each domain were summed up 
with a possible score range of 13–65. Conform with previous stud-
ies  [2, 13, 18] , the discrepancies between patients’ and caregivers’ 
total scores and scores in single domains (calculated by subtracting 
patients’ from caregivers’ estimations) were taken as measures of 
anosognosia. Positive values reﬂ ect unawareness, with higher val-
ues indicating higher degrees of unawareness. 
 Statistical Analysis 
 Statistical analyses were performed with the statistical software 
package SPSS 10.0 for Windows (SPSS Inc. UK Ltd, Surrey, UK). 
Parametric methods (two-tailed paired and unpaired t tests, Pear-
son correlations, stepwise multiple regression analysis) were used 
for normally distributed data. In case of signiﬁ cant deviations from 
the normal distribution tested with the Kolmogorov-Smirnov test, 
non-parametric methods were performed (Mann-Whitney U tests, 
Kruskal-Wallis H tests, Spearman correlations). We used the   2  test 
to compare frequencies. 
 Results 
 Subjects 
 Eighty-two AD patients (32 male) and 79 MCI subjects 
(41 male, comparable distribution for sex,   2  = 2.691, 
p = 0.101) were included in the study. Demographic and 
clinical characteristics of the groups are presented in  ta-
ble 1 . There were no signiﬁ cant differences between the 
groups regarding age, education, age at onset, and dura-
tion of illness. Mean MMSE score was signiﬁ cantly lower 
in AD than in MCI patients (t = 5.9, d.f. = 159, p  ! 0.001) 
but, as deﬁ ned in the inclusion criteria, reached  6 24 in 
all cases. In concordance with diagnostic criteria, the 
IADL scale indicated signiﬁ cantly more impaired ADL 
functions in the AD than in the MCI group (t = –7.8, d.f. = 
145, p  ! 0.001). However, the grade of impairment was 
only mild even in AD patients. Depressive symptoms (re-
ported by the caregiver) occurred in both groups with 
signiﬁ cantly higher mean scores in the AD group (t = –2.7, 
d.f. = 157, p = 0.017) but again with mild level in all 
 cases. 
 Results of the neuropsychological test battery are in-
dicated in  table 2 . While the MCI group performed below 
normative data only in verbal short- and long-term mem-
ory (CVLT), impairments in the AD group were observed 
in multiple memory tasks (CVLT, ROF delayed recall, 
digit span reverse), visuoconstructive ability (ROF copy), 
speed of processing and executive functions (Trail-Mak-
ing Test A and B), word generation (ﬂ uency), and under-
standing verbal instructions (Token Test). 
 Complaint Interview 
 Sum Scores. Results of the complaint interview are 
shown in  ﬁ gure 1 . AD patients reported signiﬁ cantly less 
cognitive dysfunction than their caregivers (21.2  8 6.3 
vs. 24.6  8 7.3, t = –4.6, d.f. = 81, p  ! 0.001). The discrep-
ancy score (caregiver minus patient reports) was above 0 
in a majority of AD subjects (median = 2, range –18 to 
26). In contrast, MCI patients reported signiﬁ cantly more 
cognitive dysfunction than their caregivers (19.8  8 5.5 
and 18.5  8 4.2, t = 2.2, d.f. = 78, p = 0.032). Accord-
ingly, the discrepancy score was frequently negative (me-
dian = –1, range –19 to 12). 
 Between-group comparison revealed comparable sum 
scores of self-complaints in AD and MCI patients (t =
–1.4, d.f. = 159, p = 0.138). In contrast, caregivers of AD 
patients reported signiﬁ cantly more dysfunctions than 
caregivers of MCI patients (t = –6.3, d.f. = 159, p  ! 0.001). 
AD (n = 82)
mean (SD), range
MCI (n = 79)
mean (SD), range
p1
Age, years 70.2 (8.7), 48–85 67.7 (8.3), 47–83 n.s.
Education, years 10.8 (4.5), 4–20 11.1 (4.6), 3–20 n.s.
Age at onset, years 67.3 (9.1), 41–81 65.4 (8.3), 45–81 n.s.
Duration of illness, months 35.4 (23.1), 6–120 29.2 (19.7), 10–120 n.s.
MMSE (max. score = 30) 25.5 (1.3), 24–28 27.0 (1.9), 24–30 ***
IADL (scale range: 8–31) 13.1 (4.5), 9–26 8.9 (1.2), 8–12 ***
HAMD (scale range: 0–65) 4.5 (4.1), 0–19 2.8 (3.4), 0–20 *
1 p value in two-tailed t test: ns = not signiﬁ cant, * p < 0.05, *** p < 0.001.
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 characteristics of the AD and MCI group 
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Accordingly, the discrepancy score was signiﬁ cantly high-
er in the AD than in the MCI group (U = 1,854.0, p  ! 
0.001). 
 Analysis of Single Domains. It was ﬁ rst analyzed how 
many functions were reported to be impaired (neglecting 
the extent of dysfunction). While caregivers of AD pa-
tients on average reported dysfunctions in 6.5  8 3.0 of 
all thirteen domains, AD patients found themselves to be 
impaired in signiﬁ cantly less functions (4.8  8 2.8, t =
–4.9, d.f. = 81, p  ! 0.001). In contrast, MCI subjects eval-
uated more domains to be deteriorated than their caregiv-
ers (self: 4.4  8 3.1, caregiver: 3.7  8 2.3, t = 3.7, d.f. = 78, 
p = 0.023). Between-group comparison showed that while 
caregivers’ evaluations signiﬁ cantly differed (t = –6.5, 
d.f. = 159, p  ! 0.001), AD and MCI patients’ reports were 
comparable (t = –0.7, d.f. = 159, p = 0.455). 
 Secondly the discrepancy between patients’ and care-
givers’ reports in the extent of impairment was examined 
for each domain ( ﬁ g. 2 ). We found signiﬁ cant differences 
for orientation to space, executive functioning, abstract 
thinking, and calculation in the AD group. MCI subjects 
reported signiﬁ cantly more pronounced dysfunction in 
word ﬁ nding. 
 Correlations and Stepwise Regression Analysis. Bivar-
iate correlations and stepwise regression analysis were 
performed to analyze the relationships of the complaint 
interview to clinical and sociodemographic variables ( ta-
ble 3 ). In the AD group, no relationship was found be-
tween reports of dysfunctions and MMSE scores. IADL 
scores were positively related to caregiver estimations of 
cognitive dysfunction and to the discrepancy score (both 
p  ! 0.001, the latter correlation indicating higher degrees 
of self-unawareness in patients with more IADL dysfunc-
tions). HAMD scores of AD patients were positively as-
sociated to self and caregiver estimations of cognitive 
 dysfunctions (so that higher cognitive impairment was 
reported in more depressed AD subjects), while the dis-
 Fig. 1. Results of the complaint interview. Higher complaint scores 
indicate higher estimations of dysfunction. Signiﬁ cant differences 
of caregivers’ from patients’ evaluations are indicated. *** p  ! 
0.001, * p  ! 0.05. 
 Table 2. Neuropsychological test battery 
Max. AD (n = 78)
mean (SD)
MCI (n = 48)
mean (SD)
Normative data1
mean (SD)
CVLT short delay free recall 16 2.4 (2.3)*** 5.2 (3.5)*** 12.1 (3.2)2
CVLT long delay free recall 16 2.2 (2.6)*** 5.4 (3.8)*** 11.2 (2.8)2
Rey-Osterrieth-Figure copy 36 26.1 (8.5)** 31.7 (4.5) 33.2 (4.0)
Rey-Osterrieth-Figure delayed recall 36 4.4 (4.8)* 10.8 (7.5) 16.7 (11.8)
Digit span forward 12 5.7 (1.5) 6.2 (1.8) 6.9 (1.7)
Digit span reverse 12 4.0 (1.9)* 4.7 (1.8) 5.9 (1.7)
Trail Making Test Part A (percentile) 100 20.7 (22.2)* 39.1 (27.6) 50 (20)
Trail Making Test B (percentile) 100 19.2 (18.7)** 37.3 (28.4) 50 (20)
Fluency: animals (z-scores) –1.2 (0.9)* –0.5 (1.2) 0 (1)
AAT: naming objects 30 28.0 (2.6) 29.1 (1.5) 28.4 (1.8)
AAT: Token test 50 (errors) 2.7 (4.8) 0.4 (1.3) 1.3 (1.6)
* 1 SD, ** 1.5 SD, *** 2 SD below normative data.
1 Performance of control subjects indicated in test manuals.
2 Data from 34 age-matched healthy controls recruited in different centers participating in the NEST-DD 
 project.
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crepancy score was negatively associated with the HAMD 
(p  ! 0.01, less discrepancy in more depressed AD pa-
tients). Age was negatively related to self-reports of dys-
function (p  ! 0.01), so that younger AD patients reported 
more cognitive deﬁ cit. 
 In the MCI group, MMSE scores correlated positively 
with self-estimations of dysfunctions and negatively with 
the discrepancy score (p  ! 0.05, indicating more com-
plaints and higher discrepancies in patients with less cog-
nitive deﬁ cits). There was a trend for signiﬁ cance (p = 
0.081) for a relationship between self-evaluation of cogni-
tive dysfunction and HAMD. Furthermore, HAMD was 
signiﬁ cantly related to caregiver evaluations of dysfunc-
tions (p  ! 0.05). While age was negatively related to self-
reports, education was positively related to self and care-
givers’ estimation of cognitive dysfunction (p  ! 0.05, i.e. 
a higher rate of cognitive impairment is reported when 
MCI patients have a higher education). No relationships 
were found between the interview and duration of illness 
in either group. 
 A stepwise regression analysis was performed using 
self and caregiver evaluations as dependant variables and 
MMSE, IADL, HAMD scores, age and education as pre-
dictive variables. In the AD group, self-complaints for 
cognitive dysfunction were signiﬁ cantly explained by the 
factor age (p = 0.006) (F = 8.102, R2 = 0.106) while care-
giver reports were dependent on IADL (p = 0.002) and 
HAMD (p = 0.002) (F = 16.917, R2 = 0.336, p  ! 0.001). 
In the MCI group, self-reports of dysfunction were pre-
 Fig. 2. Mean discrepancies of patients and 
caregiver reports of impairment in single 
functions that were assessed in the inter-
view. Values are calculated by subtracting 
patients’ from caregiver reports with posi-
tive values indicating lower estimation of 
dysfunction in patients (i.e., underestima-
tion of deﬁ cit by the patient). Signiﬁ cant 
deviations are indicated with * p  ! 0.05, 
*** p  ! 0.001. 
 Table 3. Correlations of self and caregiver ratings and of discrep-
ancy scores in the complaint interview with psychological scales, 
demographic and clinical variables 
Patient
estimation
cognition, r
Caregiver
estimation
cognition, r
Discrepancy
score cognition
rho
MMSE
AD
MCI
0.15 0.15 0.01
0.28* –0.15 –0.36**
IADL
AD
MCI
–0.07 –0.47*** –0.41***
–0.18 –0.18 –0.03
HAMD
AD
MCI
–0.24* –0.48** –0.23**
–0.19 –0.23* –0.01
Age
AD
MCI
–0.33** –0.11 –0.15
–0.28** –0.16 –0.25*
Education
AD
MCI
–0.10 –0.16 –0.13
–0.28* –0.29** –0.10
Disease duration
AD
MCI
–0.13 –0.19 –0.13
–0.12 –0.14 –0.05
* p < 0.05, ** p < 0.01, *** p < 0.001.
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dicted by the factors age (p  ! 0.001) and HAMD (p = 
0.002) (F = 6.714, R2 = 0.157). Caregiver reports were 
solely explained by the patients’ education (F = 5.390, 
R2 = 0.056, p = 0.023). 
 Discussion 
 Our results suggest that anosognosia measured by a 
discrepancy between self and caregiver reports of dys-
function is a frequent symptom in very mild AD (MMSE 
 6 24) but not in MCI. 
 Most  [2, 3, 5, 10, 15, 16, 19–21] but not all  [13, 17, 18, 
22] previous studies examining anosognosia in AD 
showed a relationship between diminished self-insight 
and dementia severity but usually did not include mild 
AD patients with MMSE scores of  6 24. In contrast to 
our ﬁ ndings, Zanetti et al.  [20], who examined AD pa-
tients from mild to severe stages of disease, found high 
self-awareness of function in mildly affected patients 
(MMSE  6 24) but linear decline of insight from moderate 
(MMSE 13–23) to severe stages (MMSE  ^  12) of disease. 
The inconsistency may be due to methodological differ-
ences (smaller patient sample, other insight scales). In our 
early stage AD sample, no relationship was found be-
tween the ‘anosognosia score’ and MMSE score. How-
ever, anosognosia measurement had a high clinical rele-
vance, since everyday functioning measured by the IADL 
was a clear predictor for lack of insight both in our study 
and in that of Migliorelli et al.  [5] . Finally, in line with 
previous studies  [8], our results suggest that age, educa-
tion, and disease duration are unrelated to self-unaware-
ness in AD. 
 Other studies examining awareness of single functions 
revealed that lack of insight might be domain-speciﬁ c  [7] . 
Our own analyses conﬁ rm that the degree of awareness is 
variable for different cognitive abilities and that under-
estimation of dysfunction in mild AD is prominent for 
executive functions (which have been documented to be 
closely linked to self-awareness  [13–15] ), and abstract 
thinking. The remarkable ﬁ nding that memory was not 
judged differentially by our AD patients and their care-
givers suggests that lack of insight into memory impair-
ment might develop in later stages of the disease and pos-
sibly explains the relationship between dementia severity 
and anosognosia revealed in other studies. 
 For our MCI sample we found that patients reported 
more cognitive impairment compared to their caregivers. 
Thus either MCI patients’ self-reports might not be reli-
able or they might feel more cognitive difﬁ culties than 
noticed by their caregivers. Previous ﬁ ndings already sug-
gested that self-reports are not a reliable measure to reﬂ ect 
past, current or future dysfunction in age-associated 
memory impairment, mild cognitive disorder and aging-
associated cognitive decline  [41, 42] . However, misjudge-
ments of dysfunction in such patients have usually been 
found in the sense of an underestimation. Albert et al. 
 [43] examined self and informant reports of functional 
abilities in patients with minimal cognitive impairment 
(CDR = 0) and questionable dementia (CDR = 0.5) and 
detected comparable complaints among both groups but 
lower correlations for self versus informant reports in 
CDR = 0.5 patients indicating an underestimation of def-
icits. Tabert et al.  [29] studied MCI patients using a lon-
gitudinal design and found that discrepancies between 
informants’ and patients’ reports of dysfunction occurred 
in a subgroup of their patients and (retrospectively) pre-
dicted future diagnosis of AD. Differences in the inclu-
sion criteria of patients should be considered as a possible 
source of inconsistencies in the results. While our MCI 
patients by deﬁ nition had memory complaints and dys-
functions but performed within a normal range in every-
day functioning, Tabert et al.  [29] deﬁ ned MCI in a 
broader sense as cognitive deﬁ cits that exceed benign ag-
ing but are not severe enough for dementia diagnosis and 
used ADL dysfunctions as their main outcome measure. 
In another study, Vogel et al.  [44] observed that impaired 
insight in memory dysfunction was equally frequent in 
patients with mild AD and amnesic MCI (with CDR 
scores of 0.5 for both groups). Again, inclusion criteria for 
the MCI group differed to ours in that subjective memo-
ry complaints were not obligatory in their patients. Ad-
ditionally, lower mnestic functions were required (2 SDs 
in their study versus 1 SD below mean normative data in 
our study) and lower cognitive functions were allowed (up 
to 2 SD in their study versus 1 SD below normative data 
in our study). To summarize, our MCI sample compared 
to those in former studies is characterized by higher cog-
nitive and everyday functioning and minor memory def-
icits. Thus, while MCI patients with more pronounced 
memory deﬁ cits and minor cognitive functions (which 
are at the lower edge of the ‘normal range’) are more like-
ly to underestimate or even neglect their deﬁ cits, ‘high 
functioning’ MCI patients as examined in our study seem 
to be highly critical (or even too critical) concerning their 
cognitive functions. 
 In our MCI group self but not caregivers’ dysfunctions 
correlated with MMSE scores. This might reﬂ ect subtle 
deﬁ cits that are recognized only by the patients them-
selves but which have no overt impact on global cognitive 
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evaluation or on everyday functioning (also questioning 
how reliable caregiver reports are, see discussion below). 
However, this relationship of self-report and MMSE was 
positive suggesting that patients have a most critical view 
on their performance especially in the earliest phase of 
disease. Alternately, lesser cognitive complaint in MCI 
patients with lower MMSE score might reﬂ ect very early 
anosognosia in patients more likely to evolve to AD. 
 Several factors inﬂ uence self and caregiver evaluation 
of dysfunction. Age has an impact on self-estimation with 
younger patients reporting more cognitive dysfunction. 
Possibly deﬁ cits in younger patients contrast more obvi-
ously with premorbid functioning. Also, older patients 
may tend to consider deﬁ cits as a benign aging process. 
Different from previous studies  [8, 10, 11] , our data sug-
gest that higher education is associated with more self and 
caregiver reports of dysfunction at least for MCI patients, 
probably indicating that deﬁ cits are more evident in high 
educated individuals. In line with the literature  [12, 16, 
17] , we found that depressive symptoms measured by 
HAMD correlated to self-evaluations in the AD group 
and constituted a predictor of self-reports in the MCI 
group leading to high estimation of cognitive impair-
ment. Noteworthy, major depression was excluded in our 
subjects, and depressive symptoms were lower in our 
MCI than in our AD group (see  table 1 ). Finally, the result 
that caregivers’ reports of cognitive dysfunction is linked 
to depression points to the methodological question of 
how reliable informants’ reports are. Zanetti et al.  [45] 
demonstrated that caregivers’ view on their relatives’ 
functional state is inﬂ uenced by caregivers’ burden and 
should thus be regarded as a subjective measure. Conse-
quently the use of discrepancy scores for the study of 
anosognosia seems somewhat limited  [46] . However, sev-
eral studies suggest that informant complaints are much 
more reliable than individual complaints  [17, 41, 42] , and 
that informant reports of memory loss distinguished non-
demented from demented individuals and predicted lat-
er development of AD  [47] . 
 From a clinical point of view, our ﬁ nding that AD and 
MCI patients’ self-evaluations of cognitive dysfunction 
are comparable is of utmost relevance. It alerts the clini-
cian to the fact that self-reports of impairments even in 
mildly affected patients cannot be regarded as reliable 
and might constitute an overestimation (most probably 
in MCI patients) or an underestimation (in AD patients) 
of the actual clinical impairment; moreover, self-evalua-
tion is inﬂ uenced by different factors such as age and 
 affect. 
 In summary, while most MCI patients tend to overes-
timate impairments, anosognosia in the sense of an un-
derestimation of dysfunction must be regarded as a clin-
ical symptom of very mild AD (MMSE scores of  6 24). 
We conclude that medical history even in mildly affected 
patients should always include information both from the 
patient and the caregiver. 
 Acknowledgements 
 This study was supported by the 5th EU Framework Program 
(NEST-DD). We thank X. Delbeuck and P. Marique for their con-
tribution in collecting neuropsychological data. 
 References 
 1 Agnew SK, Morris RG: The heterogeneity of 
anosognosia for memory impairment in Alz-
heimer’s disease: A review of the literature and 
a proposed model. Aging Ment Health 1998;  2: 
 7–19. 
 2 Derouesné C, Thibault S, Lagha-Pierucci S, 
Baudouin-Madec V, Ancri D, Lacomblez L: 
Decreased awareness of cognitive deﬁ cits in 
patients with mild dementia of the Alzheimer 
type. Int J Geriatr Psychiatry 1999;  14:  1019–
1030. 
 3 Wagner MT, Spangenberg KB, Bachman DL, 
O’Connell P: Unawareness of cognitive deﬁ cit 
in Alzheimer disease and related dementias.
Alzheimer Dis Assoc Disord 1997;  11:  125–
131. 
 4 Mullen R, Howard R, David A, Raymond L: 
Insight in Alzheimer’s disease. Int J Geriatr 
Psychiatry 1996;  11:  645–651. 
 5 Migliorelli R, Teson A, Sabe L, Petracca G, 
Petracchi M, Leiguarda R, Starkstein SE: 
Anosognosia in Alzheimer’s disease: A study of 
associated factors. J Neuropsychiatry Clin 
Neurosci 1995;  7:  338–344. 
 6 Koltai DC, Welsh-Bohmer KA, Schmechel 
DE: Inﬂ uence of anosognosia on treatment 
outcome among dementia patients. Neuropsy-
chol Rehabil 2001;  11:  455–475. 
 7 Starkstein SE, Sabe L, Chemerinski E, Jason L, 
Leiguarda R: Two domains of anosognosia in 
Alzheimer’s disease. J Neurol Neurosurg Psy-
chiatry 1996;  61:  485–490. 
 8 Vasterling JJ, Seltzer B, Watrous WE: Longi-
tudinal assessment of deﬁ cit unawareness in 
Alzheimer’s disease. Neuropsychiatry Neuro-
psychol Behav Neurol 1997;  10:  197–202. 
 9 Kotler-Cope S, Camp CJ: Anosognosia in Alz-
heimer disease. Alzheimer Dis Assoc Disord 
1995;  9:  52–56. 
 10 Gil R, Arroyo-Anllo EM, Ingrand P, Gil M, 
Neau JP, Ornon C, Bonnaud V: Self-conscious-
ness and Alzheimer’s disease. Acta Neurol 
Scand 2001;  104:  296–300. 
 11 Sevush S, Leve N: Denial of memory deﬁ cit in 
Alzheimer’s disease. Am J Psychiatry 1993; 
 150:  748–751. 
 12 Feher EP, Roderick K, Mahurin K, Inbody SB, 
Crook TH, Pirozzolo FJ: Anosognosia in Alz-
heimer’s disease. Neuropsychiatry Neuropsy-
chol Behav Neurol 1991;  4:  136–146. 
 13 Michon A, Deweer B, Pillon B, Agid Y, Dubois 
B: Relation of anosognosia to frontal lobe dys-
function in Alzheimer’s disease. J Neurol Neu-
rosurg Psychiatry 1994;  57:  805–809. 
 14 Lopez OL, Becker JT, Somsak D, Dew MA, 
DeKosky ST: Awareness of cognitive deﬁ cits 
and anosognosia in probable Alzheimer’s dis-
ease. Eur Neurol 1994;  34:  277–282. 
 Kalbe et al. 
 
 Dement Geriatr Cogn Disord 2005;19:349–356 356
 15 Ott BR, Laﬂ eche G, Whelihan WM, Buongior-
no GW, Albert MS, Fogel BS: Impaired aware-
ness of deﬁ cits in Alzheimer disease. Alzhei-
mer Dis Assoc Disord 1996;  10:  68–76. 
 16 Harwood DG, Sultzer DL, Wheatley MV: Im-
paired insight in Alzheimer disease: Associa-
tion with cognitive deﬁ cits, psychiatric symp-
toms, and behavioral disturbances. Neuro - 
psychiatry Neuropsychol Behav Neurol 2000; 
 13:  83–88. 
 17 Förstl H, Geiger-Kabisch C, Sattel H, Besthorn 
C, Schreiter-Gasser U, Abrahams CM, Biedert 
S: Self-rating and informant’s rating of clinical 
disorders in Alzheimer’s disease. Fortschr 
Neurol Psychiat 1996;  64:  228–233. 
 18 Seltzer B, Vasterling JJ, Mathias CW, Brennan 
A: Clinical and neuropsychological correlates 
of impaired awareness of deﬁ cits in Alzheimer 
disease and Parkinson disease: A comparative 
study. Neuropsychiatry Neuropsychol Behav 
Neurol 2001;  14:  122–129. 
 19 Sevush S: Relationship between denial of 
memory deﬁ cit and dementia severity in Alz-
heimer disease. Neuropsychiatry Neuropsy-
chol Behav Neurol 1999;  12:  88–94. 
 20 Zanetti O, Vallotti B, Frisoni GB, Geroldi C, 
Bianchetti A, Pasqualetti P, Trabucchi M: In-
sight in dementia: When does it occur? Evi-
dence for a nonlinear relationship between in-
sight and cognitive status. J Gerontol B Psychol 
Sci Soc Sci 1999;  54:P100–P106. 
 21 McDaniel KD, Edland SD, Heyman A, Inves-
tigators CC: Relationship between level of in-
sight and severity of dementia in Alzheimer 
disease. Alzheimer Dis Assoc Disord 1995;  9: 
 101–104. 
 22 Starkstein SE, Sabe L, Cuerva AG, Kuzis G, 
Leiguarda R: Anosognosia and procedural 
learning in Alzheimer’s disease. Neuropsychia-
try Neuropsychol Behav Neurol 1997;  10:  96–
101. 
 23 Folstein MF, Folstein SE, McHugh PR: ‘Mini-
mental state’. A practical method for grading 
the cognitive state of patients for the clinician. 
J Psychiatr Res 1975;  12:  189–198. 
 24 Hughes CP, Berg L, Danziger WL, Coben LA, 
Martin RL: A new clinical scale for the staging 
of dementia. Br J Psychiatry 1982;  140:  566–
572. 
 25 Petersen RC, Doody R, Kurz A, Mohs RC, 
Morris JC, Rabins PV, Ritchie K, Rossor M, 
Thal L, Winblad B: Current concepts in mild 
cognitive impairment. Arch Neurol 2001;  58: 
 1985–1992. 
 26 Shah Y, Tangalos EG, Petersen RC: Mild cog-
nitive impairment. When is it a precursor to 
Alzheimer’s disease? Geriatrics 2000;  55:  62, 
65–68. 
 27 Sramek JJ, Veroff AE, Cutler NR: The status 
of ongoing trials for mild cognitive impair-
ment. Expert Opin Investig Drugs 2001;  10: 
 741–752. 
 28 Larrieu S, Letenneur L, Orgogozo JM, Fabri-
goule C, Amieva H, Le Carret N, Barberger-
Gateau P, Dartigues JF: Incidence and out-
come of mild cognitive impairment in a 
population-based prospective cohort. Neurol-
ogy 2002;  59:  1594–1599. 
 29 Tabert MH, Albert SM, Borukhova-Milov L, 
Camacho Y, Pelton G, Liu X, Stern Y, Deva-
nand DP: Functional deﬁ cits in patients with 
mild cognitive impairment: Prediction of AD. 
Neurology 2002;  58:  758–764. 
 30 American Psychiatric Association: Diagnostic 
and Statistical Manual of Mental Disorders, ed 
4. APA, 1994. 
 31 McKhann G, Drachman D, Folstein M, 
Katzman R, Price D, Stadlan EM: Clinical di-
agnosis of Alzheimer’s disease: Report of the 
NINCDS-ADRDA Work Group under the 
auspices of Department of Health and Human 
Services Task Force on Alzheimer’s Disease. 
Neurology 1984;  34:  939–944. 
 32 Petersen RC, Smith GE, Waring SC, Ivnik RJ, 
Tangalos EG, Kokmen E: Mild cognitive im-
pairment: Clinical characterization and out-
come. Arch Neurol 1999;  56:  303–308. 
 33 Cummings JL, Mega M, Gray K, Rosenberg-
Thompson S, Carusi DA, Gornbein J: The 
Neuropsychiatric Inventory: Comprehensive 
assessment of psychopathology in dementia. 
Neurology 1994;  44:  2308–2314. 
 34 Delis DC, Kramer JH, Kaplan E, Ober BA: 
California Verbal Learning Test, Adult Ver-
sion. San Antonio, The Psychological Corpora-
tion, 1987. 
 35 Spreen O, Strauss E: A Compendium of Neu-
ropsychological Tests: Administration, Norms, 
and Commentary. New York, Oxford Univer-
sity Press, 1998. 
 36 Wechsler D: Wechsler Memory Scale, ed 3. San 
Antonio, The Psychological Corporation, 
1997. 
 37 Reitan R, Wolfson D: The Halstead-Reitan 
Neuropsychological Test Battery, Theory and 
clinical interpretation. Tucson, Neuropsychol-
ogy Press, 1993. 
 38 Huber W, Poeck K, Willmes K: The Aachen 
Aphasia Test. Adv Neurol 1984;  42:  291–303. 
 39 Lawton MP, Brody EM: Assessment of older 
people: Self-maintaining and instrumental ac-
tivities of daily living. Am J Psychiatry 1969; 
 154:  609–615. 
 40 Hamilton M: Development of a rating scale for 
primary depressive illness. Br J Soc Clin Psy-
chol 1967;  6:  278–296. 
 41 Jorm AF, Christensen H, Korten AE, Hender-
son AS, Jacomb PA, Mackinnon A: Do cogni-
tive complaints either predict future cognitive 
decline or reﬂ ect past cognitive decline? A lon-
gitudinal study of an elderly community sam-
ple. Psychol Med 1997;  27:  91–98. 
 42 Carr DB, Gray S, Baty J, Morris JC: The value 
of informant versus individual’s complaints of 
memory impairment in early dementia. Neu-
rology 2000;  55:  1724–1726. 
 43 Albert SM, Michaels K, Padilla M, Pelton G, 
Bell K, Marder K, Stern Y, Devanand DP: 
Functional signiﬁ cance of mild cognitive im-
pairment in elderly patients without a demen-
tia diagnosis. Am J Geriatr Psychiatry 1999;  7: 
 213–220. 
 44 Vogel A, Stokholm J, Gade A, Andersen BB, 
Heijl AM: Awareness of deﬁ cits in mild cogni-
tive impairment and Alzheimer’s disease: Do 
MCI patients have impaired insight? Dement 
Geriatr Cogn Disord 2004;  17:  181–187. 
 45 Zanetti O, Geroldi C, Frisoni GB, Bianchetti 
A, Trabucchi M: Contrasting results between 
caregiver’s report and direct assessment of ac-
tivities of daily living in patients affected by 
mild and very mild dementia: The contribu-
tion of the caregiver’s personal characteristics. 
J Am Geriatr Soc 1999;  47:  196–202. 
 46 Lamar M, Lasarev MR, Libon DJ: Determin-
ing levels of unawareness in dementia research. 
J Neuropsychiatry Clin Neurosci 2002;  14: 
 430–437. 
 47 Tierney MC, Herrmann N, Geslani DM, Sza-
lai JP: Contribution of informant and patient 
ratings to the accuracy of the Mini Mental State 
Examination in predicting probable Alzhei-
mer’s disease. J Am Geriatr Soc 2003;  51:  813–
818. 
 
